Allegion Jumps 13% in a Week. The Options Market Just Noticed.
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ALLE has gained 13.3% over the past week to $176.52, a move that stands out sharply against the median gain of 5.4% among its closest building-products peers. The prior earnings preview, published October 19, described a stock drifting quietly higher. The print on Monday morning changes that framing: what was a low-conviction grind has become a sharp re-rating, and options positioning has pivoted to reflect it.
The clearest shift is in the options market. The put/call ratio hit 0.23 on October 22, more than two standard deviations above its 20-day average of 0.14, the most defensive reading in that window even as the stock was posting its strongest week in months. That divergence is unusual: buyers were simultaneously driving the price up and paying more for downside protection than at any recent point. The borrow market, by contrast, adds no drama. Availability is exceptionally loose at roughly 6,950%, meaning the lending pool holds roughly 70 shares available for every one currently borrowed. Short interest has fallen 34% over the past month to 3.1% of the free float. There is no short-side pressure in the setup.
The Street has been playing catch-up to a stock that has moved faster than most targets. The consensus price target is $179.91 against a current price of $176.52, a gap that has been nearly closed by the rally. The recent analyst history is mixed in direction. Morgan Stanley raised its target to $160 in August but kept an Equal-Weight rating. JP Morgan and BofA both lifted targets after Q2 results in July, yet also maintained Neutral stances. Longbow Research upgraded to Buy in June with a $165 target, now below where the stock trades. The picture is one of analysts who have been incrementally more positive but have not committed to the upside that the price has already delivered. The forward P/E has expanded roughly two points over the past month to 18.2x, and EV/EBITDA has risen more than a full turn to 14.4x, compressing the margin for disappointment at Monday's print.
Peer context sharpens the picture. AWI added 3.2% on the week, AOS 3.1%, MAS 7.4%, and LPX 9%. ALLE's 13.3% gain outpaced all of them. The previous Q2 print produced a muted reaction: the stock rose 2.3% on the day and 1.8% over the following five sessions, suggesting the company does not historically deliver the kind of blowout beats that justify pre-earnings surges of this size. Wikipedia attention for Allegion has picked up modestly relative to the prior 90 days, though that dataset has no measured lead on the company's financials.
Monday's print will test whether Q3 results and guidance can justify a valuation that has re-rated faster in one week than analysts have moved their targets in the past three months.
Stocks in this article
See the live data behind this article on ORTEX.
Open ALLE on ORTEX →How this article was generated
- Generated
- 23 Oct 2026, 04:11
- Data as of
- 23 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.